Stoke Therapeutics Net Profit Margin Growth & History (STOK)
Stoke Therapeutics's net profit margin was −3.73% for fiscal 2025.
View full Stoke Therapeutics company overviewStoke Therapeutics annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3.73% | +239.68 pp |
| 2024 | 2024-12-31 | −243.42% | +949.05 pp |
| 2023 | 2023-12-31 | −1,192.47% | −377.74 pp |
| 2022 | 2022-12-31 | −814.73% | — |
Stoke Therapeutics quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −660.78% | −490.83 pp |
| Q1 2026 | 2026-03-31 | −802.75% | −873.93 pp |
| Q4 2025 | 2025-12-31 | −4,132.24% | −4085.89 pp |
| Q3 2025 | 2025-09-30 | −360.68% | +179.37 pp |
| Q2 2025 | 2025-06-30 | −169.96% | +361.92 pp |
| Q1 2025 | 2025-03-31 | 71.19% | +696.76 pp |
| Q4 2024 | 2024-12-31 | −46.35% | +916.09 pp |
| Q3 2024 | 2024-09-30 | −540.05% | +201.85 pp |
| Q2 2024 | 2024-06-30 | −531.88% | — |
| Q1 2024 | 2024-03-31 | −625.57% | −187.97 pp |
| Q4 2023 | 2023-12-31 | −962.44% | −177.65 pp |
| Q3 2023 | 2023-09-30 | −741.90% | +156.93 pp |
| Q1 2023 | 2023-03-31 | −437.60% | +384.04 pp |
| Q4 2022 | 2022-12-31 | −784.80% | — |
| Q3 2022 | 2022-09-30 | −898.83% | — |
| Q2 2022 | 2022-06-30 | −762.98% | — |
| Q1 2022 | 2022-03-31 | −821.63% | — |
Stoke Therapeutics net profit margin trends
Between the periods ended 2022-12-31 and 2025-12-31, Stoke Therapeutics's net profit margin increased from −814.73% to −3.73%, a change of +810.99 percentage points. The latest reported quarter, Q2 2026, shows −660.78%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Stoke Therapeutics source filings ↗